104 related articles for article (PubMed ID: 573534)
1. Therapy of Crohn's disease with metronidazole -- an uncontrolled trial --.
Kasper H; Sommer H; Kühn HA
Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):217-21. PubMed ID: 573534
[TBL] [Abstract][Full Text] [Related]
2. Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.
Prantera C; Berto E; Scribano ML; Falasco G
Ital J Gastroenterol Hepatol; 1998 Dec; 30(6):602-6. PubMed ID: 10076781
[TBL] [Abstract][Full Text] [Related]
3. Metronidazole therapy for Crohn's disease and associated fistulae.
Jakobovits J; Schuster MM
Am J Gastroenterol; 1984 Jul; 79(7):533-40. PubMed ID: 6741906
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
[TBL] [Abstract][Full Text] [Related]
5. [The course of Crohn disease and side effect profile with long-term treatment using metronidazole].
Gugler R; Jensen JC; Schulte H; Vogel R
Z Gastroenterol; 1989 Nov; 27(11):676-82. PubMed ID: 2515668
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole therapy for perineal Crohn's disease: a follow-up study.
Brandt LJ; Bernstein LH; Boley SJ; Frank MS
Gastroenterology; 1982 Aug; 83(2):383-7. PubMed ID: 7084615
[TBL] [Abstract][Full Text] [Related]
7. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.
Prantera C; Zannoni F; Scribano ML; Berto E; Andreoli A; Kohn A; Luzi C
Am J Gastroenterol; 1996 Feb; 91(2):328-32. PubMed ID: 8607501
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
[TBL] [Abstract][Full Text] [Related]
9. Healing of perineal Crohn's disease with metronidazole.
Bernstein LH; Frank MS; Brandt LJ; Boley SJ
Gastroenterology; 1980 Aug; 79(2):357-65. PubMed ID: 7399243
[TBL] [Abstract][Full Text] [Related]
10. Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
Hanauer SB; Krawitt EL; Robinson M; Rick GG; Safdi MA
Am J Gastroenterol; 1993 Sep; 88(9):1343-51. PubMed ID: 8362827
[TBL] [Abstract][Full Text] [Related]
11. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
Chrissafidou A; Malek M; Musch E
Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of Crohn's disease with metronidazole (author's transl)].
Schneider MU; Strobel S; Riemann JF; Demling L
Dtsch Med Wochenschr; 1981 Sep; 106(36):1126-9. PubMed ID: 6114847
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of topical metronidazole (10 percent) in the treatment of anorectal Crohn's disease.
Stringer EE; Nicholson TJ; Armstrong D
Dis Colon Rectum; 2005 May; 48(5):970-4. PubMed ID: 15785894
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
Myrelid P; Svärm S; Andersson P; Almer S; Bodemar G; Olaison G
Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
[TBL] [Abstract][Full Text] [Related]
15. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
[TBL] [Abstract][Full Text] [Related]
16. Perineal Crohn's disease complicated by pyogenic liver abscess during metronidazole therapy.
Hatoff DE
Gastroenterology; 1983 Jul; 85(1):194-5. PubMed ID: 6852451
[TBL] [Abstract][Full Text] [Related]
17. [Follow up of Crohn's disease under therapy with hydro-MRI].
Ganten M; Encke J; Flosdorff P; Grüber-Hoffmann B; Erb G; Hansmann J
Radiologe; 2003 Jan; 43(1):26-33. PubMed ID: 12552372
[TBL] [Abstract][Full Text] [Related]
18. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group.
Ludwig D; Stange EF
Z Gastroenterol; 1999 Nov; 37(11):1085-91. PubMed ID: 10604222
[TBL] [Abstract][Full Text] [Related]
20. Open label trial of clarithromycin therapy in Japanese patients with Crohn's disease.
Inoue S; Nakase H; Matsuura M; Ueno S; Uza N; Kitamura H; Mikami S; Tamaki H; Kasahara K; Chiba T
J Gastroenterol Hepatol; 2007 Jul; 22(7):984-8. PubMed ID: 17608842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
